MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1556/oh.2011.28987

Медицинская библиотека · Orvosi hetilap · 2011

[Adverse events during biological therapy -- focusing on dermatological side-effects].

Nagy Gabriella, Lukács Katalin, Sziray Agnes, Fazekas Katalin, Florián Agnes, Tamási László, Károlyi Zsuzsánna

Аннотация на английскомСтатьяПеревод пока не подготовлен

Аннотация

UNLABELLED: Biological response modifiers, especially tumour necrosis factor inhibitors have been proved to be very effective in the treatment of various immune mediated rheumatological, gastroenterological and dermatological diseases in the last 15 years. With their increasing use, the incidence of their adverse effects are more precisely defined. The aim of this cohort study was to analyse the adverse effects occurred within the study period in patients receiving biological therapy for rheumatological and dermatological autoimmune diseases.

METHODS

324 patients within a 3 years study period were treated with biological response modifiers (adalimumab: 92, etanercept: 107, infliximab: 125). The primary diagnoses were rheumotoid arthritis (n = 174), ankylosing spondylitis (n = 60), psoriatic arthritis (n = 11), and psoriasis vulgaris (79).

RESULTS

Hypersensitive reactions were observed in 11 of the patients (3.4%), 7 of which were serious and needed treatment termination. Infections constituted the majority of side effects, which were localised to skin in 10 (3.1%) and to respiratory tract in 9 (2.8%). However, most of these were mild or moderate reactions. Malignant skin tumour developed in 1 case (0.3%) only. Drug induced inflammatory disorders occurred in some cases: onset of new psoriasis was observed in 1 and flares of the existing disease were detected in additional three. Lichenoid exanthema developed in one. (n = 5, 1.5%)

CONCLUSION

The use of TNF-α blockers may provoke a broad spectrum of dermatological side effects. Our results suggest that the majority of these are infectious and inflammatory disorders, the latter may relatively often appear as drug induced psoriasis. The occurrence of malignancies was very low in our series.

Для цитирования: Nagy Gabriella, Lukács Katalin, Sziray Agnes, Fazekas Katalin, Florián Agnes, Tamási László, Károlyi Zsuzsánna. [Adverse events during biological therapy -- focusing on dermatological side-effects].. Orvosi hetilap. 2011. DOI: 10.1556/oh.2011.28987.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.